Zdrowie i gospodarka · 29/07/2021

FDA Draft Guidance for Industry: Rabies Monoclonal Antibody Cocktails for Post-Exposure Prophylaxis

The Food and Drug Administration (FDA) has released a draft guidance for industry on developing monoclonal antibody cocktails for post-exposure prophylaxis against rabies, aiming to provide an alternative to immunoglobulin for immediate treatment after exposure to a potentially rabid animal.